Infectious Diseases News and Research

RSS

Cerus receives $1.4 million to support development of INTERCEPT red blood cell system

Cerus Corporation announced today that it has received an additional $1.4 million from the U.S. Department of Defense to support advanced development of the company's pathogen inactivation technology for red blood cells. The INTERCEPT red blood cell system is a pathogen inactivation product Cerus is developing to prevent the transmission of infectious diseases through red blood cell transfusions.

24 Sep 2010

Past exposure to pathogens leads to disease resistance spreading through populations

A study by researchers at Royal Holloway, University of London, University College London and Oxford University, has found that a genetic variant which reduces the chance of contracting diseases such as tuberculosis and leprosy is more prevalent in populations with long histories of urban living.

24 Sep 2010

AJMS journal provides research update on new infectious pathogens

Newly recognized disease-causing viruses, bacteria, and other infections are continually emerging around the world, posing difficult challenges for patient diagnosis and treatment and for public health responses. A special symposium section of the September issue of The American Journal of the Medical Sciences (AJMS), official journal of the Southern Society for Clinical Investigation, provides a research update on important new infectious pathogens.

24 Sep 2010

Global Strategy for Women's and Children's Health draws more than $40 billion in resources

Culminating a global summit on the Millennium Development Goals (MDGs), United Nations Secretary-General Ban Ki-moon and Heads of State and Government, along with the private sector, foundations, international organizations, civil society and research organizations, kicked off a concerted world-wide effort to save the lives of more than 16 million women and children.

23 Sep 2010

LSUHSC hosts international scientific conference on drug abuse research and politics

Topics ranging from the future of addiction research and treatment to the binational implications of Mexico's decriminalization of drugs will be presented at the 10th Annual International Conference of the National Hispanic Science Network (NHSN) on Drug Abuse September 30 - October 2, 2010 at The Westin New Orleans Canal Place.

23 Sep 2010

Vaxonco initiates Phase I clinical trial of novel DNA-based polyepitope vaccine against malaria

Vaxonco Inc., a Korean company specializing in peptide-based vaccines and Ichor Medical Systems (Ichor), whose advanced TriGrid™ Delivery System (TriGrid™) is being tested worldwide for its ability to enhance delivery of DNA drugs and vaccines, announced today the initiation of a Phase I clinical trial to evaluate a novel DNA-based polyepitope vaccine against malaria.

23 Sep 2010

Metabolon publishes biomarker validation study results for periodontal diseases

Metabolon, Inc., leaders in global metabolomics, biomarker discovery and biochemical analysis, announces the publication of "Assessment of Dentifrice on Periodontal Disease Biomarkers in Gingival Crevicular Fluid", in the Journal of Periodontology.

23 Sep 2010

MDI and Integrated Sciences enter exclusive distribution agreement for Detect-Ready MRSA assay in Australia

Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Integrated Sciences Pty. Ltd. today announced that they have entered into an exclusive distribution agreement for MDI's Detect-Ready MRSA assay in Australia.

22 Sep 2010

Telomere length associated with higher rate of relapse and lower overall survival in aplastic anemia patients

Among patients receiving immunosuppressive therapy for severe aplastic anemia (a condition in which the bone marrow is unable to produce blood cells), the length of telomeres (chromosome markers of biological aging) was not related to the response to treatment but was associated with a higher rate of relapse (return to low blood cell counts) and lower overall survival, according to a study in the September 22/29 issue of JAMA.

22 Sep 2010

Lilly's multidrug-resistant tuberculosis initiative honored with World Business and Development Award

An eminent international panel of judges has selected Eli Lilly and Company to receive a World Business and Development Award for demonstrating what can be achieved through successful partnerships in the battle against multidrug-resistant tuberculosis (MDR-TB).

22 Sep 2010

MIDAS researchers continue to model how H1N1 may spread

As the United States prepares for the upcoming flu season, a group of researchers supported by the National Institutes of Health continues to model how H1N1 may spread.

22 Sep 2010

First free-standing infectious disease hospital built in US in over 50 years

Many Americans think tuberculosis (TB) has been eliminated in this country. But, while it is no longer as common or deadly as it was decades ago, it is estimated that more than a third of the world's population is infected with the disease. The new Texas Center for Infectious Disease (TCID) hospital was designed to provide patients with the care and treatment needed to help curb the resurgence of TB in the United States and reduce the drug-resistance of strains developing worldwide.

22 Sep 2010

Mobile Aspects releases next version of RFID enabled iRIScope endoscope tracking system

Mobile Aspects announced today the commercial availability of an enhanced design of its RFID enabled endoscope tracking system, iRIScope. Targeted at increasing care quality and patient safety, iRIScope 2.0 offers additional functional and technical capabilities to help care providers enhance their processes for endoscope storage, use and reprocessing.

22 Sep 2010

HIV infection mystery revealed

In a new discovery, Melbourne researchers have found a mechanism by which the HIV virus can affect people. According to co-head of the Burnet Institute's Centre for Virology, Sharon Lewin, scientists have found out how HIV entered a group of cells in which the virus tends to persist in spite of antiviral treatment that reduces the virus to undetectable levels.

22 Sep 2010

Aethlon Medical reestablishes efforts to advance Aethlon Hemopurifier

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, disclosed today that it has reestablished efforts to advance the Aethlon Hemopurifier within U.S. Government programs that support the development and purchase of treatment countermeasures against bioterror threats.

21 Sep 2010

Cytheris commences enrollment in CYT107 recombinant human Interleukin-7 clinical trial for HIV

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in INSPIRE 3, a Phase II clinical program evaluating the effect of repeated cycles of the company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in the treatment of chronically HIV-1 infected patients classified as Immunological Non-Responders (INR) after at least 24 months of highly active anti-retroviral therapy (HAART).

21 Sep 2010

USAID, GAIN announce $1 million to reduce malnutrition burden

The United States Agency for International Development (USAID) and the Global Alliance for Improved Nutrition (GAIN) announced today $1 million to expand efforts to reduce the growing burden of malnutrition. The announcement will be made today at a historic gathering of the First Ladies of Africa, who convened to declare nutrition as a critical priority for eliminating poverty, improving health and advancing food security in their nations.

21 Sep 2010

Annals of Internal Medicine publishes GRACE study data on HIV therapy

Data from the GRACE study will be published in the September 21st issue of the Annals of Internal Medicine. GRACE is the largest-ever study of treatment experienced adult women with HIV-1 to examine gender differences in response to HIV therapy. Sponsored by Tibotec Therapeutics Clinical Affairs, a division of Centocor Ortho Biotech Services, LLC, the GRACE study enrolled 67 percent women, demonstrating that it is possible to recruit large numbers of women into U.S.-based HIV treatment studies.

21 Sep 2010

Researchers to develop vaccine for plague

Given the many pressing concerns of the day, fear of plague probably isn't what causes most Americans to lose sleep. But for those whose responsibility it is to combat bioterrorism, plague is among the highest priorities. Those charged with that mission include scientists like medical researcher Steve Smiley, whose lab at the Trudeau Institute is working to develop a vaccine that will protect the public against weaponized forms of plague.

21 Sep 2010

Inovio Pharmaceuticals completes enrollment for PENNVAX-B vaccine Phase I clinical study

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the Phase I clinical study assessing Inovio's PENNVAX-B DNA vaccine delivered using its proprietary electroporation technology in a preventive setting has fully completed the enrollment of 48 healthy volunteers. The multi-center study is being conducted by Inovio's clinical collaborator, the HIV Vaccine Trials Network (HVTN), at several clinical sites under a protocol designated HVTN-080.

21 Sep 2010

Infectious Diseases News and Research

Cerus receives $1.4 million to support development of INTERCEPT red blood cell system

Past exposure to pathogens leads to disease resistance spreading through populations

AJMS journal provides research update on new infectious pathogens

Global Strategy for Women's and Children's Health draws more than $40 billion in resources

LSUHSC hosts international scientific conference on drug abuse research and politics

Vaxonco initiates Phase I clinical trial of novel DNA-based polyepitope vaccine against malaria

Metabolon publishes biomarker validation study results for periodontal diseases

MDI and Integrated Sciences enter exclusive distribution agreement for Detect-Ready MRSA assay in Australia

Telomere length associated with higher rate of relapse and lower overall survival in aplastic anemia patients

Lilly's multidrug-resistant tuberculosis initiative honored with World Business and Development Award

MIDAS researchers continue to model how H1N1 may spread

First free-standing infectious disease hospital built in US in over 50 years

Mobile Aspects releases next version of RFID enabled iRIScope endoscope tracking system

HIV infection mystery revealed

Aethlon Medical reestablishes efforts to advance Aethlon Hemopurifier

Cytheris commences enrollment in CYT107 recombinant human Interleukin-7 clinical trial for HIV

USAID, GAIN announce $1 million to reduce malnutrition burden

Annals of Internal Medicine publishes GRACE study data on HIV therapy

Researchers to develop vaccine for plague

Inovio Pharmaceuticals completes enrollment for PENNVAX-B vaccine Phase I clinical study

NGS for Infectious Disease Surveillance eBook

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News